Review
Copyright ©The Author(s) 2016.
World J Stem Cells. Jan 26, 2016; 8(1): 1-12
Published online Jan 26, 2016. doi: 10.4252/wjsc.v8.i1.1
Table 2 Use of mesenchymal stem cells and bone morphogenetic proteins in cartilage and bone defects in vivo
ConditionsScaffoldRef.
MSCs and BMPs in cartilage defects
MSCs transfected with BMP7Bioresorbable polimer scaffold[94]
MSCs transfected with BMP7 and TGF-β1Bilayered osteochondral scaffold[95]
MSCs + TGF-β1, PDGF and BMP2Bilayer scaffold with platelet rich plasma[96]
MSCs + TGF-β1, TGF-β3, BMP2, 4 and 7Osteochondral allograft with extracellular matrix proteins[98]
MSCs and BMPs in bone defects
MSCs transfected with BMP2Animal models of ectopic and orthotopic bone formation[103-110]
MSCs transfected with BMP2Alginate or type I collagen hydrogels[111]
MSCs transfected with BMP2Injectable chitosan biopolymer and inorganic phosphate[112]
MSCs + BMP2Macroporous β-tricalcium phosphate deposited by robocasting[72]
MSCs + BMP7Natural bone mineral particles[113]
MSCs + BMP73D collagen nanofiber implant[114]